GB1359226A - Propylene carbonate medicament base composition - Google Patents

Propylene carbonate medicament base composition

Info

Publication number
GB1359226A
GB1359226A GB4193171A GB4193171A GB1359226A GB 1359226 A GB1359226 A GB 1359226A GB 4193171 A GB4193171 A GB 4193171A GB 4193171 A GB4193171 A GB 4193171A GB 1359226 A GB1359226 A GB 1359226A
Authority
GB
United Kingdom
Prior art keywords
weight percent
alkyl
alcohols
propylene carbonate
polysiloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4193171A
Inventor
S Shastri
Z I Shaikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of GB1359226A publication Critical patent/GB1359226A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Abstract

1359226 Medicament base compositions SYNTEX CORP 8 Sept 1971 [29 Oct 1970] 41932/71 Heading A5B A composition, useful as a medicament base, consists essentially of (a) from 0.1 to 30 weight percent propylene carbonate; b) from 30 to 99.5 weight percent petrolatum or polysiloxane or mixtures thereof; c) compatible cosolvent and coupling agent, the concentration of which in combination with the propylene carbonate is from 0.5 to 70 weight percent; (d) from 0 to 45 weight percent pharmaceutically acceptable surfactant; (e) from 0 to 20 weight percent thickener: and (f) from 0 to 25 weight percent penetrant. The pentrolatum may be a paraffinic mineral oil or paraffin wax; and the polysiloxane may have organic moieties such as C 1-8 alkyl, C 1-8 alkenyl, phenyl, alkyl-substituted phenyl, and phenyl alkyl (e.g. benzyl) attached to the polysiloxane, dimethylpolysolixane being preferred; the compatible cosolvent and coupling agent may be chosen from mono-, di- or poly-hydric alcohols, alkyl ethers of glycols, polyethylene or polypropylene glycol, esters of aliphatic mono- and di-basic acids and mono-, di- and polyhydric alcohols, sugar alcohols or a sterol such as cholesterol; the surfactant may be anionic, cationic, amphoteric or nonionic; the thickener may be colloidal alumina or silica, alginic acid or derivatives thereof, carboxyvinyl polymer, cellulose derivatives (such as methyl cellulose, hydroxyethyl cellulose or sodium carboxymethyl cellulose), gelatin, gums (such as agar, tragacanth, acacia or guar gum), egg yolk, lecithin, pectin, thixcin or resins (such as ethyleneoxide polymers); and the penetrant may be a dialkyl sulphoxide, dimethyl-formamide, dimethylacetamide, tetrahydrofuran or tetrahydrofurfuryl alcohol. The composition may also contain beeswax, spermaceti, paraffin waxes, fatty acids, alcohols and amides; a penetration aid such as squalene or acetylated lanolin fractions and/or a preservative. The composition may contain a therapeutic agent for topical application such as an antibiotic, e.g. oxytetracylcline, chlorotetracycline, streptomycin, bacitracin, chloramphenicol or tyrothricin; a steroid; an antihistamine such as prophenpyridamine maleate or diphenhydramine hydrochloride; an anaesthetic such as benzocaine or lidocaine; an antibacterial such as iodine, nitrofurazone, sulphanilamide and derivatives, or benzalkonium chloride; a fungicide such as undecylenic acid; coal tar, balsum Peru, ammoniated mercury, chrysarobin, ichthammol or sulphur.
GB4193171A 1970-10-29 1971-09-08 Propylene carbonate medicament base composition Expired GB1359226A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8524670A 1970-10-29 1970-10-29

Publications (1)

Publication Number Publication Date
GB1359226A true GB1359226A (en) 1974-07-10

Family

ID=22190384

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4193171A Expired GB1359226A (en) 1970-10-29 1971-09-08 Propylene carbonate medicament base composition

Country Status (17)

Country Link
JP (1) JPS5410613B1 (en)
AT (1) AT310948B (en)
BE (1) BE774489A (en)
CA (1) CA989306A (en)
CH (1) CH566783A5 (en)
DE (1) DE2153779C3 (en)
DK (1) DK129766B (en)
ES (2) ES396479A1 (en)
FI (1) FI52811C (en)
FR (1) FR2111912B1 (en)
GB (1) GB1359226A (en)
IL (1) IL37614A (en)
NL (1) NL164199C (en)
NO (1) NO133998C (en)
SE (1) SE377042B (en)
YU (1) YU268471A (en)
ZA (1) ZA715709B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116423A (en) * 1982-01-13 1983-09-28 Quinoderm Ltd Dermatological compositions
US4626529A (en) * 1981-10-23 1986-12-02 L'oreal Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin
EP2319510A1 (en) * 2009-10-02 2011-05-11 Johnson and Johnson Consumer Companies, Inc. Benzoyl peroxide composition for treating skin

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
FR2205358B1 (en) * 1972-11-03 1976-04-23 Rhone Poulenc Ind
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626529A (en) * 1981-10-23 1986-12-02 L'oreal Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin
GB2116423A (en) * 1982-01-13 1983-09-28 Quinoderm Ltd Dermatological compositions
EP2319510A1 (en) * 2009-10-02 2011-05-11 Johnson and Johnson Consumer Companies, Inc. Benzoyl peroxide composition for treating skin

Also Published As

Publication number Publication date
NL164199C (en) 1980-12-15
ZA715709B (en) 1972-11-29
DE2153779B2 (en) 1974-08-29
CA989306A (en) 1976-05-18
YU268471A (en) 1984-06-30
IL37614A (en) 1974-05-16
AT310948B (en) 1973-10-25
CH566783A5 (en) 1975-09-30
FR2111912B1 (en) 1975-02-07
NO133998C (en) 1976-08-04
DK129766B (en) 1974-11-18
JPS5410613B1 (en) 1979-05-08
ES396479A1 (en) 1975-02-16
BE774489A (en) 1972-02-14
NO133998B (en) 1976-04-26
SE377042B (en) 1975-06-23
DE2153779C3 (en) 1975-04-24
AU3322871A (en) 1973-03-15
DK129766C (en) 1975-04-28
ES423345A1 (en) 1976-06-01
FI52811B (en) 1977-08-31
FR2111912A1 (en) 1972-06-09
FI52811C (en) 1977-12-12
IL37614A0 (en) 1971-11-29
NL7114957A (en) 1972-05-03
DE2153779A1 (en) 1972-06-08

Similar Documents

Publication Publication Date Title
US4195085A (en) Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
KR890701084A (en) Composition and administration method of eye drops cyclospoorin
LU90677I2 (en) Esomeprazole and its pharmaceutically acceptable salts and derivatives (nexiam)
HUT49280A (en) Ointment for the peroral administration of medicine and process for producing the composition
KR890015729A (en) Anesthetic skin moisturizing composition and preparation method thereof
DE3065420D1 (en) Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
IL58782A (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
GB1359226A (en) Propylene carbonate medicament base composition
US2730483A (en) Therapeutic compositions comprising neomycin, gramicidin and quaternary ammonium salt of thonzylamine
US3888995A (en) Fatty alcohol-propylene glycol vehicle
ATE41012T1 (en) (8S)-8-FLUOROERYTHROMYCIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR850000974A (en) Process for preparing pharmaceutical composition containing liquid lubricant
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
KR900016156A (en) Quinoxaline derivatives and ulcers
GB1183299A (en) Foam Bath Compositions
GB1454389A (en) Nasal decongestants nasal decongestants
IE44167B1 (en) Ophthalmic compositions
IT1164677B (en) 1,3 BENZODIOXY DERIVATIVES PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE INCREDIENTS
GB843134A (en) Improvements in and relating to pharmaceutical compositions
HUT59597A (en) Process for producing pharmaceutical compositions contaiing pharmaceutically active tetrahydro-naphtalene derivatives
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.
ES8401483A1 (en) Furobenzazepines, their production and pharmaceutical compositions containing them
BE882020A (en) SUBSTITUTED BENZHYDRINDANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
RU94027137A (en) Medicinal vaseline

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years